133 related articles for article (PubMed ID: 37245712)
1. Risk of Severe Infection in Patients With Biopsy-proven Nonalcoholic Fatty Liver Disease - A Population-based Cohort Study.
Ebrahimi F; Simon TG; Hagström H; Söderling J; Wester A; Roelstraete B; Ludvigsson JF
Clin Gastroenterol Hepatol; 2023 Dec; 21(13):3346-3355.e19. PubMed ID: 37245712
[TBL] [Abstract][Full Text] [Related]
2. Cancer Risk in Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.
Simon TG; Roelstraete B; Sharma R; Khalili H; Hagström H; Ludvigsson JF
Hepatology; 2021 Nov; 74(5):2410-2423. PubMed ID: 33811766
[TBL] [Abstract][Full Text] [Related]
3. Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort.
Simon TG; Roelstraete B; Hagström H; Sundström J; Ludvigsson JF
Gut; 2022 Sep; 71(9):1867-1875. PubMed ID: 34489307
[TBL] [Abstract][Full Text] [Related]
4. Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort.
Simon TG; Roelstraete B; Khalili H; Hagström H; Ludvigsson JF
Gut; 2021 Jul; 70(7):1375-1382. PubMed ID: 33037056
[TBL] [Abstract][Full Text] [Related]
5. Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortality.
Simon TG; Roelstraete B; Hartjes K; Shah U; Khalili H; Arnell H; Ludvigsson JF
J Hepatol; 2021 Nov; 75(5):1034-1041. PubMed ID: 34224779
[TBL] [Abstract][Full Text] [Related]
6. Progression of non-alcoholic fatty liver disease and long-term outcomes: A nationwide paired liver biopsy cohort study.
Simon TG; Roelstraete B; Hagström H; Loomba R; Ludvigsson JF
J Hepatol; 2023 Dec; 79(6):1366-1373. PubMed ID: 37604268
[TBL] [Abstract][Full Text] [Related]
7. Familial coaggregation of MASLD with hepatocellular carcinoma and adverse liver outcomes: Nationwide multigenerational cohort study.
Ebrahimi F; Hagström H; Sun J; Bergman D; Shang Y; Yang W; Roelstraete B; Ludvigsson JF
J Hepatol; 2023 Dec; 79(6):1374-1384. PubMed ID: 37647992
[TBL] [Abstract][Full Text] [Related]
8. Risk of infections in non-alcoholic fatty liver disease: A nationwide population-based cohort study.
Shang Y; Widman L; Ebrahimi F; Ludvigsson JF; Hagström H; Wester A
Liver Int; 2023 Oct; 43(10):2142-2152. PubMed ID: 37475642
[TBL] [Abstract][Full Text] [Related]
9. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD.
Hagström H; Nasr P; Ekstedt M; Hammar U; Stål P; Hultcrantz R; Kechagias S
J Hepatol; 2017 Dec; 67(6):1265-1273. PubMed ID: 28803953
[TBL] [Abstract][Full Text] [Related]
10. Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver Disease.
Simon TG; Henson J; Osganian S; Masia R; Chan AT; Chung RT; Corey KE
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2776-2784.e4. PubMed ID: 31077838
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic steatohepatitis is associated with a higher risk of advanced colorectal neoplasm.
Cho Y; Lim SK; Joo SK; Jeong DH; Kim JH; Bae JM; Park JH; Chang MS; Lee DH; Jung YJ; Kim BG; Kim D; Lee KL; Kim W
Liver Int; 2019 Sep; 39(9):1722-1731. PubMed ID: 31162812
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration.
Patel YA; Gifford EJ; Glass LM; McNeil R; Turner MJ; Han B; Provenzale D; Choi SS; Moylan CA; Hunt CM
Aliment Pharmacol Ther; 2018 Jan; 47(2):268-278. PubMed ID: 29115682
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic use and development of nonalcoholic fatty liver disease: A population-based case-control study.
Ebrahimi F; Simon TG; Hagström H; Sun J; Bergman D; Forss A; Roelstraete B; Engstrand L; Ludvigsson JF
Liver Int; 2023 Oct; 43(10):2186-2197. PubMed ID: 37387502
[TBL] [Abstract][Full Text] [Related]
14. Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease.
Henson JB; Simon TG; Kaplan A; Osganian S; Masia R; Corey KE
Aliment Pharmacol Ther; 2020 Apr; 51(7):728-736. PubMed ID: 32043602
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease risk in paediatric and young adult non-alcoholic fatty liver disease.
Simon TG; Roelstraete B; Alkhouri N; Hagström H; Sundström J; Ludvigsson JF
Gut; 2023 Mar; 72(3):573-580. PubMed ID: 36522149
[TBL] [Abstract][Full Text] [Related]
16. Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
Chan TT; Chan WK; Wong GL; Chan AW; Nik Mustapha NR; Chan SL; Chong CC; Mahadeva S; Shu SS; Lai PB; Chan HL; Wong VW
Am J Gastroenterol; 2020 Jun; 115(6):867-875. PubMed ID: 32149781
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary function is associated with fibrosis severity in patients with biopsy-proven nonalcoholic fatty liver disease.
Lee HW; Lee DH; Lee JK; Lee S; Koo BK; Joo SK; Heo EY; Jung YJ; Kim W; Kim DK
Liver Int; 2020 Dec; 40(12):3008-3017. PubMed ID: 32737958
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological Profile and Outcome of a Large Cohort of Patients with Nonalcoholic Fatty Liver Disease from South Asia: Interim Results of the Indian Consortium on Nonalcoholic Fatty Liver Disease.
Duseja A; Singh SP; Mehta M; Shalimar ; Venkataraman J; Mehta V; Devadas K; Kar SK; Goyal O; Nagral A; Saigal S; Nijhawan S; Praharaj D; Shukla A; Sharma B; Narayanasamy K; Kumar P; Rao PN; Arora A; Mehta R; Asati P; Ranjan P; Koshy A; Alam S; Mukewar S; Mukewar S; Mohan Prasad VG; Rastogi M; Sanyal AJ
Metab Syndr Relat Disord; 2022 Apr; 20(3):166-173. PubMed ID: 35085026
[No Abstract] [Full Text] [Related]
19. Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease.
Bessissow T; Le NH; Rollet K; Afif W; Bitton A; Sebastiani G
Inflamm Bowel Dis; 2016 Aug; 22(8):1937-44. PubMed ID: 27379445
[TBL] [Abstract][Full Text] [Related]
20. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
